Medicine and Dentistry
Breast Cancer
100%
Overall Survival
51%
Patient
41%
Next Generation Sequencing
38%
Metastatic Breast Cancer
37%
Neoplasm
37%
Progression Free Survival
30%
Lymphocyte
30%
Inpatient
28%
Adjuvant Chemotherapy
27%
Epidermal Growth Factor Receptor
27%
Onset Age
26%
Fluorodeoxyglucose F 18
26%
Survival
24%
Non Small Cell Lung Cancer
23%
Triple Negative Breast Cancer
23%
Gamma Urogastrone
22%
Lung Cancer
22%
Hazard Ratio
21%
Prognostic Factor
20%
Bone Metastasis
19%
Tumor Infiltrating Lymphocyte
19%
Positron Emission Tomography-Computed Tomography
19%
Clinical Feature
18%
Small Cell Lung Cancer
17%
Disease Free Survival
17%
Lymphocyte
16%
Neutrophil
16%
Neutrophil
16%
Recurrence Free Survival
16%
Malignant Neoplasm
16%
Gene Expression
15%
Epidermal Growth Factor Receptor 2
15%
Breast
14%
Anthracycline
14%
Immunohistochemistry
14%
Abdominal Cancer
13%
Programmed Death 1 Ligand 1
13%
Clear Cell Renal Cell Carcinoma
13%
Lymphovascular Invasion
13%
Glucose Transporter 1
13%
Peripheral T-Cell Lymphoma
13%
Purpura
13%
Carcinoid Tumor of Lung
13%
Pneumonectomy
13%
Male Breast Cancer
13%
Meta-Analysis
13%
Breast Carcinoma
13%
Tumor Gene
13%
Breast Tumor
13%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
51%
Overall Survival
46%
Chemotherapy
44%
Metastatic Breast Cancer
39%
Breast Cancer
33%
Progression Free Survival
27%
Doxorubicin
23%
Non Small Cell Lung Cancer
21%
Triple Negative Breast Cancer
21%
Anthracycline
19%
Taxane
19%
Neoplasm
18%
Capecitabine
17%
Overall Survival
16%
Gemcitabine
15%
Cardiotoxicity
15%
Gamma Urogastrone
14%
Recurrent Disease
14%
Immune Checkpoint Inhibitor
14%
Epidermal Growth Factor Receptor
14%
Epithelium Tumor
13%
Gemcitabine
13%
Palbociclib
13%
Fluorodeoxyglucose F 18
13%
Meningoencephalitis
13%
Intraductal Carcinoma
13%
Small Cell Lung Cancer
13%
Carcinoembryonic Antigen
13%
Epidermal Growth Factor Receptor Kinase Inhibitor
13%
Bone Metastasis
13%
Metastatic Colorectal Cancer
13%
Listeria monocytogenes
13%
Retrospective Study
13%
Glucose Transporter 1
13%
Antibiotics
13%
Transforming Growth Factor Beta
13%
Neoplasm
11%
Neutropenia
11%
Hormone Receptor
10%
Diseases
10%
microRNA
9%
Carcinoembryonic Antigen
9%
Platinum
8%
Trastuzumab
7%
Toxicity
7%
Monotherapy
7%
Malignant Neoplasm
7%
Survival
7%
Disease
6%
Malignant Neoplasm
6%
Biochemistry, Genetics and Molecular Biology
Overall Survival
23%
Next Generation Sequencing
21%
SOX2
19%
Epidermal Growth Factor Receptor
19%
Colon
16%
Fusion Gene
13%
KIF5B
13%
Tumor Gene
13%
KRAS
13%
Antibiotic Sensitivity
13%
Tumor Gene
13%
Homologous Recombination
11%
Cancer Cell
9%
Disease Free Survival
9%
Gene Expression Data
9%
Whole Genome Sequencing
9%
Circulating Tumor DNA
8%
Phenol Red
7%
Anthracycline
6%
Capecitabine
6%
Neutrophil-To-Lymphocyte Ratio
6%
Case Report
6%
Age
6%
Immune Checkpoints
6%
Mutated Genes
6%
Homologous Recombination
6%
Saponin
6%
Plasmid
6%
Phylogeny
6%
Doxorubicin
6%
Androgen Receptor
6%
Saponin
6%
Escherichia coli
6%
Escherichia coli
6%
NLRP2
6%
Angiogenesis
6%
Angiogenesis
6%
Cancer Staging
6%
Tumor-Infiltrating Lymphocytes
6%
Carvedilol
6%
Carcinoembryonic Antigen
6%
Overall Survival
5%
Estrogen Receptor
5%
Progesterone Receptor
5%
Survival
5%